GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Cyclically Adjusted PS Ratio

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Cyclically Adjusted PS Ratio : (As of Jun. 19, 2024)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio falls into.



Skystar Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Skystar Bio-Pharmaceutical Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, Skystar Bio-Pharmaceutical Co's adjusted Revenue per Share data for the three months ended in Sep. 2014 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=2.141/98.9000*98.9000
=2.141

Current CPI (Sep. 2014) = 98.9000.

Skystar Bio-Pharmaceutical Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200412 0.000 74.488 0.000
200503 3.405 75.597 4.455
200506 0.849 74.618 1.125
200509 0.680 75.290 0.893
200512 0.913 75.666 1.193
200603 0.757 76.340 0.981
200606 1.438 76.034 1.870
200609 1.411 76.413 1.826
200612 0.684 77.793 0.870
200703 0.535 78.884 0.671
200706 0.966 79.357 1.204
200709 1.574 81.276 1.915
200712 1.422 82.911 1.696
200803 0.747 85.485 0.864
200806 1.219 85.058 1.417
200809 2.695 85.057 3.134
200812 2.242 83.956 2.641
200903 1.024 84.457 1.199
200906 1.670 83.615 1.975
200909 1.819 84.369 2.132
200912 1.526 85.386 1.768
201003 0.682 86.316 0.781
201006 1.157 85.886 1.332
201009 2.598 87.267 2.944
201012 2.201 89.289 2.438
201103 0.987 91.154 1.071
201106 1.269 91.612 1.370
201109 2.915 92.711 3.110
201112 2.176 92.885 2.317
201203 1.099 94.367 1.152
201206 1.189 93.495 1.258
201209 1.175 94.482 1.230
201212 1.033 95.237 1.073
201303 0.726 96.372 0.745
201306 1.488 95.984 1.533
201309 2.099 97.332 2.133
201312 1.238 97.624 1.254
201403 0.887 98.600 0.890
201406 1.826 98.200 1.839
201409 2.141 98.900 2.141

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Skystar Bio-Pharmaceutical Co  (GREY:SKBI) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Skystar Bio-Pharmaceutical Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines